FDA Approves SIR-Spheres for Liver Cancer Treatment
The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in the U.S. for both...
The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in the U.S. for both...
Donation and Transplant activities in Mexico occur in heterogeneous, changing, and adverse landscapes. States that have made efforts to increase...
This study highlights the significant impact of a structured training program in enhancing the knowledge and skills of CHOs regarding...
NHS patients at a Cambridge hospital will be the first in Europe to receive a new ultrasound liver cancer treatment.The treatment...
The study explored the views of healthcare providers in three health facilities regarding the barriers to accessing haemodialysis in northern...
Brauer, M. et al. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational...